Square Pharms Plc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SQUARE PHARMS PLC
SQUARE PHARMS PLC has five approved drugs.
Summary for Square Pharms Plc
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Square Pharms Plc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Square Pharms Plc | METHIMAZOLE | methimazole | TABLET;ORAL | 218830-002 | Feb 5, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Square Pharms Plc | MIRTAZAPINE | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 205798-003 | Jun 1, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Square Pharms Plc | VALSARTAN | valsartan | TABLET;ORAL | 205347-004 | Apr 9, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
